Infection risk remains a prominent clinical concern for patients with multiple myeloma (MM), even with the advent of modern, ...
Bispecific antibody therapy is transforming cancer treatment, especially in multiple myeloma, with ongoing studies exploring ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback